TMO
July 23, 2025 - AI Summary
Undervalued by 35.5% based on the discounted cash flow analysis.
Market cap | $205.16 Billion |
---|---|
Enterprise Value | $235.82 Billion |
Dividend Yield | $1.68 (0.31%) |
Earnings per Share | $16.58 |
Beta | 0.78 |
Outstanding Shares | 378,000,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 31.19 |
---|---|
PEG | 838.45 |
Price to Sales | 4.77 |
Price to Book Ratio | 4.09 |
Enterprise Value to Revenue | 5.46 |
Enterprise Value to EBIT | 49.59 |
Enterprise Value to Net Income | 35 |
Total Debt to Enterprise | 0.15 |
Debt to Equity | 0.7 |
No data
No data
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Its Mission is to enable our customers to make the world healthier, cleaner and safer. Whether the customers are acceleratin...